Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by 18falffapi Petct 18ffdg Petct

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed2
Recruiting1
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (4)

Research Network

Common Treatments

  • 18falffapi Petct 18ffdg Petct1
  • Screening System For Ocular Surface Malignant Tumors1
  • Orbital Bone Reconstruction With Preformed Titanium Plate Preoperatively Bended On Stereolithographic Model1
  • Multiparametric Mri And Image Analysis By Deep Learning Or Machine Learning Algorithms1
  • Orbital Bone Reconstruction With Patient Specific Titanium Implant1

Active Sponsors

  • Sun Yat-sen University1
  • Peking University Third Hospital1
  • Hatem Adel Aboelhassan1
  • Beijing Tongren Hospital1

Top Investigators

Related Conditions

  • Eye Neoplasms1
  • Conjunctival Neoplasms1
  • Maxillary Cyst1
  • Orbital Bone Fracture1
  • Maxillary Neoplasms1

Activity Timeline